The prolific country artist has battled Charcot-Marie-Tooth disease for over a decade. Here's what to know about the ...

The prolific country artist from Georgia has battled Charcot-Marie-Tooth disease for over a decade. Here's what to know about it.

Country music legend Alan Jackson battles Charcot-Marie-Tooth disease a progressive nerve condition affecting movement and ...

Augustine Therapeutics has raised €78 million ($85 million) in first-round funding for a pipeline headed by a candidate for ...

The tour began in 2022 and is set to continue through 2025. Jackson's final tour continues amid his battle with Charcot-Marie-Tooth disease, a chronic neuropathy condition he first revealed in 2021.

Alan Jackson performed at the 100th anniversary of the Grand Ole Opry, amidst his tour battling Charcot-Marie-Tooth disease. The condition has caused him significant motor and sensory problems.

Augustine Therapeutics has reeled in €77.7 million (about $85 million) to take on Charcot-Marie-Tooth disease, ...

Charcot-Marie-Tooth disease type 2E (CMT2E) is a slow and progressive neuropathy characterized by axonal dysfunction. Its clinical phenotype includes muscle weakness and atrophy, sensory loss and ...

The tour began in 2022 and is set to continue through 2025. Jackson's final tour continues amid his battle with Charcot-Marie-Tooth disease, a chronic neuropathy condition he first revealed in 2021.

Recently, the company announced a collaboration with the Charcot–Marie–Tooth Association, a non-profit organization serving the hereditary neuropathy patient community, to validate the role of ...

Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round Novo Holdings and Jeito Capital co-led the deal, supported by Asabys Partners and existing ...